首页 | 本学科首页   官方微博 | 高级检索  
     

化痰脉通片对痰瘀型颈动脉粥样硬化患者血清ox-LDL和IL-6的调节作用观察
引用本文:黄浩,王骁腾,洪军. 化痰脉通片对痰瘀型颈动脉粥样硬化患者血清ox-LDL和IL-6的调节作用观察[J]. 勤云标准版测试, 2019, 39(10): 1267-1270
作者姓名:黄浩  王骁腾  洪军
作者单位:新疆医科大学附属中医医院, 新疆 乌鲁木齐 830000,新疆医科大学附属中医医院, 新疆 乌鲁木齐 830000,新疆医科大学附属中医医院, 新疆 乌鲁木齐 830000
基金项目:国家自然科学基金项目(81160429)。
摘    要:目的 观察化痰脉通片对痰瘀型颈动脉粥样硬化(carotid atherosclerosis,CAS)患者血清氧化型低密度脂蛋白(oxidative low-density lipoprotein,ox-LDL)及血清白细胞介素6(interleukin-6,IL-6)水平的调节作用。方法 将符合纳入标准的65例CAS患者随机分成对照组32例和治疗组33例,对照组采用阿司匹林肠溶片+阿托伐他汀钙片进行治疗;治疗组在对照组基础上联合化痰脉通片口服治疗。疗程6个月。观察比较两组治疗前后血清ox-LDL、IL-6水平和颈动脉内膜中层厚度(intima-media thickness,IMT)的变化。结果 治疗后两组血清ox-LDL水平均较治疗前降低,治疗组的变化差异有统计学意义(P<0.05),降低幅度显著大于对照组(P<0.05);治疗后两组血清IL-6水平均较治疗前有所降低,但差异无统计学意义(P>0.05);两组治疗前后IMT变化差异无统计学意义(P>0.05)。结论 对痰瘀型CAS患者采用化痰脉通片联合西药治疗可显著降低其血清ox-LDL水平,从而达到保护血管内皮的目的。

关 键 词:颈动脉粥样硬化  痰瘀型  化痰脉通片  ox-LDL  IL-6
收稿时间:2019-06-27

Observation on Regulating Effect of Huatan Maitong Tablets on Serum ox-LDL and IL-6 in Patients with Carotid Atherosclerosis of Phlegm Stasis Type
HUANG Hao,WANG Xiaoteng and HONG Jun. Observation on Regulating Effect of Huatan Maitong Tablets on Serum ox-LDL and IL-6 in Patients with Carotid Atherosclerosis of Phlegm Stasis Type[J]. , 2019, 39(10): 1267-1270
Authors:HUANG Hao  WANG Xiaoteng  HONG Jun
Affiliation:The Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University, Urumchi, Xinjiang 830000, China,The Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University, Urumchi, Xinjiang 830000, China and The Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University, Urumchi, Xinjiang 830000, China
Abstract:Objective To observe regulating effect of Huatan Maitong Tablets on oxidative low-density lipoprotein (ox-LDL) and interleukin-6 (IL-6) levels in patients with carotid atherosclerosis (CAS). Methods A total of 65 CAS patients meeting the inclusion criteria were randomly divided into control group (32 cases) and treatment group (33 cases). The control group was treated with aspirin enteric-coated tablets and atorvastatin calcium tablets; and the treatment group was additionally treated with Huatan Maitong Tablets orally on the treatment basis of the control group. The course of treatment was 6 months. Changes in serum levels of ox-LDL and IL-6, and carotid intima-media thickness (IMT) were observed and compared between the 2 groups before and after the treatment. Results After the treatment, the serum ox-LDL level in the 2 groups was decreased compared with that before the treatment, and the difference in the treatment group was statistically significant (P<0.05), with its decrease extent more obvious than that in the control group (P<0.05). After the treatment, the serum IL-6 level in the 2 groups was decreased compared with that before the treatment, but the difference was not statistically significant (P>0.05). There was no statistically significant difference in IMT between the 2 groups before and after the treatment (P>0.05). Conclusion Huatan Maitong Tablets combined with Western medicine can obviously decrease serum ox-LDL level in patients with CAS of phlegm stasis type, which can achieve the purpose of protecting vascular endothelium.
Keywords:carotid atherosclerosis  phlegm stasis type  Huatan Maitong Tablets  ox-LDL  IL-6
点击此处可从《勤云标准版测试》浏览原始摘要信息
点击此处可从《勤云标准版测试》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号